top of page
NanoGhost - pipeline header image .png

Pipeline

NanoGhost Therapeutic Pipeline

NanoGhost is developing a pipeline of encapsulated therapeutics for selective targeting to multiple oncological disorders

elements&images_1.png

Oncology

Candidate

Target Indication

Development Phase

Discovery

Preclinical

Phase I

Phase II

Phase III

NG-1001

Small Molecule, SN-38

Solid Tumors

NG-2001

mRNA

Immune Oncology, Solid Tumors

Solid Tumors

NG-3001

DNA/Oncolytic Virus
(Collaboration with Pharma Company)

bottom of page